z-logo
Premium
Hypoactive Sexual Desire Disorder in Women: Treatment Options Beyond Testosterone and Approaches to Communicating with Patients on Sexual Health
Author(s) -
Lodise Nicole M.
Publication year - 2013
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1002/phar.1209
Subject(s) - hypoactive sexual desire disorder , sexual desire , medicine , distress , testosterone (patch) , health care , reproductive health , interpersonal communication , psychotherapist , clinical psychology , psychology , human sexuality , sociology , social psychology , political science , gender studies , population , environmental health , law
Hypoactive sexual desire disorder ( HSDD ) affects nearly 1 in 10 women. Thus, it is essential for pharmacists and other health care providers to be comfortable when discussing a patient's sexual health to ensure appropriate triage so that the specific causes of HSDD can be identified and potential recommendations provided. HSDD is defined as the absence or deficiency of sexual interest and/or desire, leading to significant distress and interpersonal difficulties. As health care providers, pharmacists have a critical role in assessing the presence of HSDD and providing education on available treatment options. This article will review the potential causes of HSDD and low sexual desire, the screening tools available, and the significant role of health care professionals in communicating with patients about their sexual health. An overview of the importance of behavioral modifications, the current pharmacologic options being investigated, and the use of complementary and alternative therapies will also be explored. Currently, buproprion is the primary pharmacologic agent that has shown positive results in treating patients with HSDD . The use of testosterone therapy will not be addressed in this article, as this therapy is described in greater detail elsewhere.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here